Paliperidone Palmitate Long-Acting Injectable Given Intramuscularly in the Deltoid Versus the Gluteal Muscle Are They Therapeutically Equivalent?

被引：6
|
作者：
Ravenstijn, Paulien [1 ]
Samtani, Mahesh [2 ]
Russu, Alberto [1 ]
Hough, David [3 ]
Gopal, Srihari [3 ]
机构：
[1] Janssen Res & Dev LLC, Beerse, Belgium
[2] Janssen Res & Dev LLC, Raritan, NJ USA
[3] Janssen Res & Dev LLC, Titusville, NJ USA
来源：
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY | 2016年 / 36卷 / 06期
关键词：
SCHIZOPHRENIA; INJECTIONS;
D O I：
10.1097/JCP.0000000000000610
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：744 / 745
页数：2
相关论文
共 50 条
  • [31] Long-acting injectable paliperidone palmitate versus oral paliperidone extended release: a comparative analysis from two placebo-controlled relapse prevention studies
    Markowitz, Michael
    Fu, Dong-Jing
    Levitan, Bennett
    Gopal, Srihari
    Turkoz, Ibrahim
    Alphs, Larry
    ANNALS OF GENERAL PSYCHIATRY, 2013, 12
  • [32] Methodological challenges in indirect treatment comparisons: spotlight on a recent comparison of long-acting injectable aripiprazole versus paliperidone palmitate in the treatment of schizophrenia
    Singh, Arun
    Gopal, Srihari
    Kim, Edward
    Mathews, Maju
    Kern-Sliwa, Jennifer
    Turkoz, Ibrahim
    Wooller, Annette
    Berlin, Jesse
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2018, 33 (04) : 213 - 216
  • [33] Effects of Long-acting Injectable 3-Monthly Paliperidone Palmitate on the Clinical and Social Performance of Patients with Schizophrenia
    Oh, Jihoon
    Oh, Jihye
    Kim, Dong Wook
    Youn, HyunChul
    Kim, Sae-Hoon
    Kim, Soo In
    Chung, In Won
    Wang, Kuan Shu
    Kim, Minah
    Paik, Jong -Woo
    Koh, Min Jung
    Lee, Yoosun
    Choi, Seok Young
    Kim, Jung-Jin
    CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE, 2023, 21 (01) : 126 - 134
  • [34] Need for Bioequivalence Standards that Reflect the Clinical Importance of the Complex Pharmacokinetics of Paliperidone Palmitate Long-Acting Injectable Suspension
    Procyshyn, Ric M.
    Lamoure, Joel W.
    Katzman, Martin A.
    Skinner, Pamela L.
    Sherman, Stephen E.
    JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES, 2019, 22 : 548 - 566
  • [35] Real-life effectiveness of transitioning from paliperidone palmitate 1-monthly to paliperidone palmitate 3-monthly long-acting injectable formulation
    Corbeil, Olivier
    Essiambre, Anne-Marie
    Bechard, Laurent
    Roy, Audrey-Anne
    Huot-Lavoie, Maxime
    Brodeur, Sebastien
    Chandrasena, Ranjith
    Theriault, Chantale
    Crocker, Candice
    Melun, Jean-Pierre
    Tibbo, Phil
    Demers, Marie-France
    Roy, Marc-Andre
    THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY, 2022, 12
  • [36] Switching from risperidone long-acting injectable to paliperidone long-acting injectable or oral antipsychotics: analysis of a Medicaid claims database
    Voss, Erica A.
    Ryan, Patrick B.
    Stang, Paul E.
    Hough, David
    Alphs, Larry
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2015, 30 (03) : 151 - 157
  • [37] Economic analysis of paliperidone long-acting injectable for chronic schizophrenia in Portugal
    Einarson, Thomas R.
    Maia-Lopes, Susana
    Goswami, Pushpendra
    Bereza, Basil G.
    Van Impe, Kristel
    JOURNAL OF MEDICAL ECONOMICS, 2016, 19 (09) : 913 - 921
  • [38] Serum Concentrations of Paliperidone After Administration of the Long-Acting Injectable Formulation
    Helland, Arne
    Spigset, Olav
    THERAPEUTIC DRUG MONITORING, 2017, 39 (06) : 659 - 662
  • [39] Hospitalizations and economic analysis in psychotic patients with paliperidone palmitate long-acting injection
    Mesones-Peral, Jesus E.
    Gurillo-Munoz, Pedro
    Paz Sanchez-Sicilia, Mari
    Miller, Adam
    Grinant-Fernandez, Alejandra
    REVISTA DE PSIQUIATRIA Y SALUD MENTAL, 2017, 10 (01): : 33 - 37
  • [40] Clinical Pharmacology of Paliperidone Palmitate A Parenteral Long-Acting Formulation for the Treatment of Schizophrenia
    Gilday, Elizabeth
    Nasrallah, Henry A.
    REVIEWS ON RECENT CLINICAL TRIALS, 2012, 7 (01) : 2 - 9
12345